141 related articles for article (PubMed ID: 9467952)
1. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells.
Alblas J; Slager-Davidov R; Steenbergh PH; Sussenbach JS; van der Burg B
Oncogene; 1998 Jan; 16(1):131-9. PubMed ID: 9467952
[TBL] [Abstract][Full Text] [Related]
2. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
3. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
4. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059.
He H; Wang X; Gorospe M; Holbrook NJ; Trush MA
Cell Growth Differ; 1999 May; 10(5):307-15. PubMed ID: 10359012
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis.
Stadheim TA; Kucera GL
Biochem Biophys Res Commun; 1998 Apr; 245(1):266-71. PubMed ID: 9535820
[TBL] [Abstract][Full Text] [Related]
9. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.
Dufourny B; Alblas J; van Teeffelen HA; van Schaik FM; van der Burg B; Steenbergh PH; Sussenbach JS
J Biol Chem; 1997 Dec; 272(49):31163-71. PubMed ID: 9388270
[TBL] [Abstract][Full Text] [Related]
11. Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction.
Hazzalin CA; Le Panse R; Cano E; Mahadevan LC
Mol Cell Biol; 1998 Apr; 18(4):1844-54. PubMed ID: 9528756
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells.
Li T; Dai W; Lu L
J Biol Chem; 2002 Sep; 277(36):32668-76. PubMed ID: 12082101
[TBL] [Abstract][Full Text] [Related]
14. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
15. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
16. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.
Weber JD; Raben DM; Phillips PJ; Baldassare JJ
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):61-8. PubMed ID: 9337851
[TBL] [Abstract][Full Text] [Related]
17. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion.
Khoo S; Cobb MH
Proc Natl Acad Sci U S A; 1997 May; 94(11):5599-604. PubMed ID: 9159118
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
20. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
Chen BK; Kung HC; Tsai TY; Chang WC
Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]